Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 30, 2017

DrugPatentWatch Database Preview

Meclofenamate sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for meclofenamate sodium and what is the scope of meclofenamate sodium patent protection?

Meclofenamate sodium
is the generic ingredient in three branded drugs marketed by Watson Labs, Parke Davis, Usl Pharma, Barr, Vitarine, Am Therap, Sandoz, Par Pharm, Quantum Pharmics, and Mylan, and is included in twenty-two NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for meclofenamate sodium. One supplier is listed for this compound.

Summary for Generic Name: meclofenamate sodium

Tradenames:3
Patents:1
Applicants:10
NDAs:22
Drug Master File Entries: see list8
Suppliers / Packagers: see list1
Bulk Api Vendors: see list60
Clinical Trials: see list923
Patent Applications: see list6,553
Therapeutic Class:Anti-inflammatory Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:meclofenamate sodium at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan
MECLOFENAMATE SODIUM
meclofenamate sodium
CAPSULE;ORAL071081-001Sep 3, 1986RXNoYes► Subscribe► Subscribe
Mylan
MECLOFENAMATE SODIUM
meclofenamate sodium
CAPSULE;ORAL071081-002Sep 3, 1986RXNoNo► Subscribe► Subscribe
Vitarine
MECLOFENAMATE SODIUM
meclofenamate sodium
CAPSULE;ORAL071710-001Jun 15, 1988DISCNNoNo► Subscribe► Subscribe
Usl Pharma
MECLOFENAMATE SODIUM
meclofenamate sodium
CAPSULE;ORAL071008-001Mar 25, 1988DISCNNoNo► Subscribe► Subscribe
Parke Davis
MECLOMEN
meclofenamate sodium
CAPSULE;ORAL018006-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Predict branded drug patent expiration
  • Formulary management

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot